DMP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dermapharm Holding SE

Watchlist Manager

Watchlist

Price: 38.6 EUR -0.13%

Market Cap: €4.1B

D	Dermapharm Holding SE XMUN:DMP	DE
	Watsco Inc F:WC30	US
	Grupo Aeroportuario del Sureste SAB de CV F:AED	MX
F	Fortune Brands Innovations Inc F:2FB	US
O	Otis Worldwide Corp F:4PG	US
I	Installed Building Products Inc F:2IL	US
	Liberty Global Ltd F:3O41	BM
J	JCDecaux SE F:DCS	FR
D	Deutsche Bank AG XMUN:DBK	DE
	Telefonaktiebolaget LM Ericsson F:ERCA	SE

Profitability Summary

Dermapharm Holding SE's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

65%

Gross Margin is Increasing

64% > 68%

Healthy Operating Margin

20%

Sustainable 3Y Average Operating Margin

18%

Declining Operating Margin

22% > 20%

Healthy Net Margin

12%

Low 3Y Average Net Margin

Net Margin is Increasing

11% > 12%

Exceptional Free Cash Flow Margin

18%

Strong 3Y Average Free Cash Flow Margin

15%

Declining Free Cash Flow Margin

23% > 18%

Exceptional ROE

26%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.